garnant pharmacy limited Company Information
Group Structure
View All
Industry
Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
Registered Address
78 langland bay road, langland, swansea, SA3 4QR
Website
www.wales.nhs.ukgarnant pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GARNANT PHARMACY LIMITED at £592.3k based on a Turnover of £1.5m and 0.38x industry multiple (adjusted for size and gross margin).
garnant pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GARNANT PHARMACY LIMITED at £285k based on an EBITDA of £58.3k and a 4.89x industry multiple (adjusted for size and gross margin).
garnant pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GARNANT PHARMACY LIMITED at £590.3k based on Net Assets of £227.7k and 2.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Garnant Pharmacy Limited Overview
Garnant Pharmacy Limited is a live company located in swansea, SA3 4QR with a Companies House number of 06485658. It operates in the retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. sector, SIC Code 47749. Founded in January 2008, it's largest shareholder is s p swansea limited with a 100% stake. Garnant Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at £1.5m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Garnant Pharmacy Limited Health Check
Pomanda's financial health check has awarded Garnant Pharmacy Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
6 Weak
Size
annual sales of £1.5m, make it smaller than the average company (£12.7m)
- Garnant Pharmacy Limited
£12.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (7.1%)
- Garnant Pharmacy Limited
7.1% - Industry AVG
Production
with a gross margin of 39.9%, this company has a comparable cost of product (39.9%)
- Garnant Pharmacy Limited
39.9% - Industry AVG
Profitability
an operating margin of 0.2% make it less profitable than the average company (5.3%)
- Garnant Pharmacy Limited
5.3% - Industry AVG
Employees
with 9 employees, this is below the industry average (41)
9 - Garnant Pharmacy Limited
41 - Industry AVG
Pay Structure
on an average salary of £60.4k, the company has an equivalent pay structure (£60.4k)
- Garnant Pharmacy Limited
£60.4k - Industry AVG
Efficiency
resulting in sales per employee of £171.3k, this is less efficient (£307.3k)
- Garnant Pharmacy Limited
£307.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Garnant Pharmacy Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is slower than average (29 days)
- Garnant Pharmacy Limited
29 days - Industry AVG
Stock Days
it holds stock equivalent to 11 days, this is less than average (67 days)
- Garnant Pharmacy Limited
67 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is less cash available to meet short term requirements (16 weeks)
9 weeks - Garnant Pharmacy Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 52.8%, this is a higher level of debt than the average (47.1%)
52.8% - Garnant Pharmacy Limited
47.1% - Industry AVG
GARNANT PHARMACY LIMITED financials
Garnant Pharmacy Limited's latest turnover from July 2023 is estimated at £1.5 million and the company has net assets of £227.7 thousand. According to their latest financial statements, Garnant Pharmacy Limited has 9 employees and maintains cash reserves of £44.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 299,140 | 600,685 | |||||||||||||
Other Income Or Grants | 0 | 0 | |||||||||||||
Cost Of Sales | 214,219 | 413,510 | |||||||||||||
Gross Profit | 84,921 | 187,175 | |||||||||||||
Admin Expenses | 53,026 | 120,484 | |||||||||||||
Operating Profit | 31,895 | 66,691 | |||||||||||||
Interest Payable | 0 | 0 | |||||||||||||
Interest Receivable | 0 | 0 | |||||||||||||
Pre-Tax Profit | 31,895 | 66,691 | |||||||||||||
Tax | -6,164 | -4,423 | |||||||||||||
Profit After Tax | 25,731 | 62,268 | |||||||||||||
Dividends Paid | 0 | 0 | |||||||||||||
Retained Profit | 25,731 | 62,268 | |||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 9 | 8 | 6 | 7 | 5 | 4 | 6 | 6 | |||||||
EBITDA* | 32,008 | 66,937 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 3,415 | 4,055 | 4,592 | 1,011 | 539 | 495,662 | 779 | 892 | 1,138 | 1,405 | 1,697 | 1,810 | 1,298 | 1,267 | 1,490 |
Intangible Assets | 220,000 | 275,000 | 330,000 | 385,000 | 440,000 | 0 | 550,000 | 550,000 | 550,000 | 550,000 | 550,000 | 550,000 | 550,000 | 550,000 | 550,000 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 223,415 | 279,055 | 334,592 | 386,011 | 440,539 | 495,662 | 550,779 | 550,892 | 551,138 | 551,405 | 551,697 | 551,810 | 551,298 | 551,267 | 551,490 |
Stock & work in progress | 28,500 | 31,500 | 30,500 | 30,500 | 28,000 | 0 | 24,744 | 33,387 | 38,824 | 38,411 | 39,644 | 38,792 | 44,176 | 47,818 | 50,561 |
Trade Debtors | 0 | 0 | 248 | 148 | 45,775 | 158,632 | 100,469 | 99,146 | 52,728 | 100,637 | 109,710 | 146,030 | 165,520 | 102,490 | 104,803 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 185,762 | 174,583 | 98,318 | 78,784 | 80,069 | 0 | 8,236 | 5,259 | 9,517 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 44,439 | 47,469 | 120,048 | 108,661 | 23,854 | 0 | 84 | 312 | 339 | 484 | 385 | 1,209 | 5,723 | 1,761 | 357 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 1,734 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 258,701 | 253,552 | 249,114 | 218,093 | 177,698 | 160,366 | 133,533 | 138,104 | 101,408 | 139,532 | 149,739 | 186,031 | 215,419 | 152,069 | 155,721 |
total assets | 482,116 | 532,607 | 583,706 | 604,104 | 618,237 | 656,028 | 684,312 | 688,996 | 652,546 | 690,937 | 701,436 | 737,841 | 766,717 | 703,336 | 707,211 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 19,435 | 23,011 | 23,271 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 140,154 | 137,634 | 129,404 | 114,901 | 68,023 | 508,707 | 82,441 | 83,798 | 91,403 | 468,705 | 467,816 | 544,586 | 563,498 | 517,514 | 504,066 |
Group/Directors Accounts | 54,349 | 119,418 | 190,050 | 280,353 | 364,236 | 0 | 395,405 | 0 | 330,166 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 59,360 | 50,920 | 68,643 | 63,384 | 58,206 | 0 | 60,596 | 381,461 | 19,198 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 253,863 | 307,972 | 388,097 | 458,638 | 490,465 | 508,707 | 557,877 | 488,270 | 464,038 | 468,705 | 467,816 | 544,586 | 563,498 | 517,514 | 504,066 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,453 | 36,416 | 59,764 |
provisions | 510 | 594 | 226 | 192 | 0 | 0 | 156 | 178 | 228 | 281 | 339 | 362 | 260 | 253 | 313 |
total long term liabilities | 510 | 594 | 226 | 192 | 0 | 0 | 156 | 178 | 228 | 281 | 339 | 362 | 12,713 | 36,669 | 60,077 |
total liabilities | 254,373 | 308,566 | 388,323 | 458,830 | 490,465 | 508,707 | 558,033 | 488,448 | 464,266 | 468,986 | 468,155 | 544,948 | 576,211 | 554,183 | 564,143 |
net assets | 227,743 | 224,041 | 195,383 | 145,274 | 127,772 | 147,321 | 126,279 | 200,548 | 188,280 | 221,951 | 233,281 | 192,893 | 190,506 | 149,153 | 143,068 |
total shareholders funds | 227,743 | 224,041 | 195,383 | 145,274 | 127,772 | 147,321 | 126,279 | 200,548 | 188,280 | 221,951 | 233,281 | 192,893 | 190,506 | 149,153 | 143,068 |
Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 31,895 | 66,691 | |||||||||||||
Depreciation | 640 | 537 | 568 | 169 | 113 | 246 | 267 | 292 | 321 | 320 | 229 | 224 | 263 | ||
Amortisation | 55,000 | 55,000 | 55,000 | 55,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | -6,164 | -4,423 | |||||||||||||
Stock | -3,000 | 1,000 | 0 | 2,500 | 28,000 | -24,744 | -14,080 | -5,437 | 413 | -1,233 | 852 | -5,384 | -3,642 | -2,743 | 50,561 |
Debtors | 11,179 | 76,017 | 19,634 | -46,912 | -32,788 | 49,927 | 46,460 | 42,160 | -38,392 | -9,073 | -36,320 | -19,490 | 63,030 | -2,313 | 104,803 |
Creditors | 2,520 | 8,230 | 14,503 | 46,878 | -440,684 | 426,266 | -8,962 | -7,605 | -377,302 | 889 | -76,770 | -18,912 | 45,984 | 13,448 | 504,066 |
Accruals and Deferred Income | 8,440 | -17,723 | 5,259 | 5,178 | 58,206 | -60,596 | 41,398 | 362,263 | 19,198 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -84 | 368 | 34 | 192 | 0 | -156 | -72 | -50 | -53 | -58 | -23 | 102 | 7 | -60 | 313 |
Cash flow from operations | 25,828 | 380,399 | |||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -65,069 | -70,632 | -90,303 | -83,883 | 364,236 | -395,405 | 65,239 | -330,166 | 330,166 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12,453 | -23,963 | -23,348 | 59,764 |
share issue | |||||||||||||||
interest | 0 | 0 | |||||||||||||
cash flow from financing | -22,493 | -380,166 | |||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -3,030 | -72,579 | 11,387 | 84,807 | 23,854 | -84 | -255 | -27 | -145 | 99 | -824 | -4,514 | 3,962 | 1,404 | 357 |
overdraft | 0 | 0 | 0 | 0 | 0 | -19,435 | -3,836 | -260 | 23,271 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -3,030 | -72,579 | 11,387 | 84,807 | 23,854 | 19,351 | 3,581 | 233 | -23,416 | 99 | -824 | -4,514 | 3,962 | 1,404 | 357 |
garnant pharmacy limited Credit Report and Business Information
Garnant Pharmacy Limited Competitor Analysis
Perform a competitor analysis for garnant pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in SA3 area or any other competitors across 12 key performance metrics.
garnant pharmacy limited Ownership
GARNANT PHARMACY LIMITED group structure
Garnant Pharmacy Limited has no subsidiary companies.
garnant pharmacy limited directors
Garnant Pharmacy Limited currently has 1 director, Mr Simon Palmer serving since Aug 2017.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Simon Palmer | Wales | 62 years | Aug 2017 | - | Director |
P&L
July 2023turnover
1.5m
+13%
operating profit
2.6k
0%
gross margin
40%
+3.43%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
227.7k
+0.02%
total assets
482.1k
-0.09%
cash
44.4k
-0.06%
net assets
Total assets minus all liabilities
garnant pharmacy limited company details
company number
06485658
Type
Private limited with Share Capital
industry
47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
incorporation date
January 2008
age
17
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
July 2023
previous names
N/A
accountant
JAMES & UZZELL LTD
auditor
-
address
78 langland bay road, langland, swansea, SA3 4QR
Bank
-
Legal Advisor
-
garnant pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to garnant pharmacy limited. Currently there are 1 open charges and 2 have been satisfied in the past.
garnant pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GARNANT PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
garnant pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|